Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-25 @ 8:59 PM
Study NCT ID:
NCT00301756
Status:
COMPLETED
Last Update Posted:
2018-08-20
First Post:
2006-03-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2009-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-09
First Submit QC Date:
None
Study First Post Date:
2006-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-01
Results First Submit QC Date:
None
Results First Post Date:
2016-12-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-20
Last Update Post Date:
2018-08-20
Last Update Post Date Type:
ACTUAL